Nexentis Technologies Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

4.24M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	263.00K	-131.00K	-33.25%
Dec 31, 2022	394.00K	-44.14K	-10.07%
Dec 31, 2021	438.14K	205.87K	88.63%
Dec 31, 2020	232.27K	56.45K	32.11%
Dec 31, 2019	175.82K	-250.77K	-58.78%
Dec 31, 2018	426.59K	82.66K	24.04%
Dec 31, 2017	343.93K	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Nutrien	26.88B
The Mosaic Company	12.43B
ICL Group	7.41B
CF Industries Holdings	7.41B
The Scotts Miracle-Gro Company	3.47B
FMC Corporation	3.43B
CVR Partners	643.22M
American Vanguard	522.88M

Revenue Rankings

NXTS News

20 days ago - Nexentis Technologies says MitoCareX Bio achieves drug discovery milestone - TheFly
20 days ago - Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development - GlobeNewsWire
25 days ago - Nexentis Technologies Announces Optimization of Hit Molecule at MitoCareX Bio Representing Key Drug Discovery Milestone - GlobeNewsWire
4 weeks ago - Nexentis Technologies Inc trading halted, volatility trading pause - TheFly
4 weeks ago - Nexentis Technologies Inc trading resumes - TheFly
4 weeks ago - Nexentis Technologies announces Mitoline U.S. trademark registration approval - TheFly
4 weeks ago - Nexentis Technologies Announces U.S. Trademark Registration Approval for MitoCareX's Algorithm Platform MITOLINE™ - GlobeNewsWire
7 weeks ago - Nexentis Technologies files $100M mixed securities shelf - TheFly

More News